Cardiovascular Information System (CVIS) Market Research Report - Forecast till 2027

Cardiovascular Information System Market Research Report: by Component (Hardware, Software, Services), by Delivery Mode (Cloud-based/Web-based, On-premise), by Application (Cardiac &Peripheral Catheterization, Hemodynamic Monitoring, Electrophysiology, Echocardiography, Vascular Ultrasound, ECG/Stress/Holter Management, Nuclear Cardiology), by End User (Pharmaceutical & Biotechnology Companies, Research & Academic Centers) - Forecast Till 2027

ID: MRFR/HC/6252-CR | August, 2021 | Region : Global

LIST OF CONTENTS
1 EXECUTIVE SUMMARY 18
2 MARKET INTRODUCTION 19
2.1 SCOPE OF THE STUDY 19
2.2 RESEARCH OBJECTIVE 19
2.3 MARKET STRUCTURE 19
2.4 ASSUMPTIONS & LIMITATIONS 20
3 RESEARCH METHODOLOGY 21
3.1 DATA MINING 21
3.2 SECONDARY RESEARCH 22
3.3 PRIMARY RESEARCH 23
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24
3.5 FORECASTING TECHNIQUES 24
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26
3.6.1 BOTTOM-UP APPROACH 27
3.6.2 TOP-DOWN APPROACH 27
3.7 DATA TRIANGULATION 28
3.8 VALIDATION 28
4 MARKET DYNAMICS 29
4.1 OVERVIEW 29
4.2 DRIVERS 30
4.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES 30
4.2.2 GROWING GOVERNMENT INITIATIVES TOWARDS THE IMPLEMENTATION OF ELECTRONIC HEALTH RECORD SYSTEM 30
4.2.3 TECHNOLOGICAL ADVANCEMENTS 30
4.2.4 RISING DEMAND FOR DATA-DRIVEN TECHNOLOGIES 31
4.3 RESTRAINTS 32
4.3.1 HIGH COST OF CVIS FOLLOWED BY THE NEED FOR TRAINING 32
4.3.2 RESTRAINT IMPACT ANALYSIS 32
4.4 OPPORTUNITIES 32
4.4.1 EMERGING MARKETS OF CVIS 32
5 MARKET FACTOR ANALYSIS 33
5.1 VALUE CHAIN ANALYSIS 33
5.1.1 R&D 34
5.1.2 MANUFACTURING 34
5.1.3 DISTRIBUTION AND SALES 34
5.1.4 POST-SALES MONITORING 34
5.2 PORTER'S FIVE FORCES MODEL 35
5.2.1 BARGAINING POWER OF SUPPLIERS 35
5.2.2 BARGAINING POWER OF BUYERS 36
5.2.3 THREAT OF NEW ENTRANTS 36
5.2.4 THREAT OF SUBSTITUTES 36
5.2.5 INTENSITY OF RIVALRY 36
5.3 IMPACT OF COVID-19 ON THE CARDIOVASCULAR INFORMATION SYSTEM MARKET 36
5.3.1 OVERVIEW 36
5.3.2 IMPACT ON PRIVACY 37
5.3.3 IMPACT ON TECHNOLOGY 37
5.3.4 IMPACT ON DEMAND 37
6 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT 38
6.1 OVERVIEW 38
6.2 SOFTWARE 39
6.3 SERVICES 39
6.4 HARDWARE 40
7 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE 41
7.1 OVERVIEW 41
7.2 CLOUD-BASED/WEB-BASED 42
7.3 ON-PREMISE 42
8 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION 43
8.1 OVERVIEW 43
8.2 CARDIAC AND PERIPHERAL CATHETERIZATION 44
8.3 ECHOCARDIOGRAPHY 45
8.4 HEMODYNAMICS MONITORING 45
8.5 ELECTROPHYSIOLOGY 46
8.6 VASCULAR ULTRASOUND 46
8.7 NUCLEAR CARDIOLOGY 47
8.8 ECG/STRESS/HOLTER MANAGEMENT 47
8.9 OTHERS 48
9 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER 49
9.1 OVERVIEW 49
9.2 HOSPITAL & CLINICS 50
9.3 DIAGNOSTIC LABORATORIES 50
9.4 CARDIAC CATH LABS 51
9.5 OTHERS 51
10 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION 52
10.1 OVERVIEW 52
10.2 AMERICAS 53
10.3 NORTH AMERICA 56
10.3.1 US 58
10.3.2 CANADA 59
10.3.3 LATIN AMERICA 61
10.4 EUROPE 63
10.4.1 WESTERN EUROPE 65
10.4.1.1 GERMANY 68
10.4.1.2 FRANCE 69
10.4.1.3 UK 71
10.4.1.4 ITALY 72
10.4.1.5 SPAIN 74
10.4.1.6 REST OF WESTERN EUROPE 76
10.4.2 EASTERN EUROPE 77
10.5 ASIA-PACIFIC 79
10.5.1 CHINA 81
10.5.2 INDIA 83
10.5.3 JAPAN 84
10.5.4 AUSTRALIA 86
10.5.5 SOUTH KOREA 87
10.5.6 REST OF ASIA-PACIFIC 89
10.6 MIDDLE EAST & AFRICA 90
10.6.1 MIDDLE EAST 93
10.6.2 AFRICA 94
11 COMPETITIVE LANDSCAPE 96
11.1 OVERVIEW 96
11.2 MAJOR PLAYERS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 96
11.3 COMPETITIVE BENCHMARKING 97
11.4 COMPETITOR DASHBOARD 98
11.5 DEVELOPMENTS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 98
11.5.1 ACQUISITION 98
11.5.2 COLLABORATION 99
11.5.3 PRODUCT LAUNCH 99
11.5.4 PARTNERSHIP 99
11.6 FINANCIAL MATRIX 100
12 COMPANY PROFILES 101
12.1 GE HEALTHCARE 101
12.1.1 COMPANY OVERVIEW 101
12.1.2 FINANCIAL OVERVIEW 102
12.1.3 PRODUCTS/SERVICES OFFERED 102
12.1.4 KEY DEVELOPMENTS 103
12.1.5 SWOT ANALYSIS 103
12.1.6 KEY STRATEGIES 103
12.2 SIEMENS HEALTHINEERS 104
12.2.1 COMPANY OVERVIEW 104
12.2.2 FINANCIAL OVERVIEW 105
12.2.3 PRODUCTS/SERVICES OFFERED 105
12.2.4 KEY DEVELOPMENTS 106
12.2.5 SWOT ANALYSIS 106
12.2.6 KEY STRATEGIES 106
12.3 KONINKLIJKE PHILIPS NV 107
12.3.1 COMPANY OVERVIEW 107
12.3.2 FINANCIAL OVERVIEW 108
12.3.3 PRODUCTS/SERVICES OFFERED 108
12.3.4 KEY DEVELOPMENTS 109
12.3.5 SWOT ANALYSIS 109
12.3.6 KEY STRATEGIES 109
12.4 FUJIFILM HOLDINGS CORPORATION 110
12.4.1 COMPANY OVERVIEW 110
12.4.2 FINANCIAL OVERVIEW 111
12.4.3 PRODUCTS/SERVICES OFFERED 111
12.4.4 KEY DEVELOPMENTS 112
12.4.5 SWOT ANALYSIS 112
12.4.6 KEY STRATEGIES 112
12.5 MCKESSON CORPORATION 113
12.5.1 COMPANY OVERVIEW 113
12.5.2 FINANCIAL OVERVIEW 114
12.5.3 PRODUCTS/SERVICES OFFERED 114
12.5.4 KEY DEVELOPMENTS 115
12.5.5 SWOT ANALYSIS 115
12.5.6 KEY STRATEGIES 116
12.6 CERNER CORPORATION 117
12.6.1 COMPANY OVERVIEW 117
12.6.2 FINANCIAL OVERVIEW 117
12.6.3 PRODUCTS OFFERED 118
12.6.4 KEY DEVELOPMENTS 118
12.6.5 SWOT ANALYSIS 119
12.6.6 KEY STRATEGIES 119
12.7 IBM WATSON HEALTH 120
12.7.1 COMPANY OVERVIEW 120
12.7.2 FINANCIAL OVERVIEW 121
12.7.3 PRODUCTS OFFERED 121
12.7.4 KEY DEVELOPMENTS 122
12.7.5 SWOT ANALYSIS 122
12.7.6 KEY STRATEGIES 123
12.8 LUMEDX 124
12.8.1 COMPANY OVERVIEW 124
12.8.2 FINANCIAL OVERVIEW 124
12.8.3 PRODUCTS OFFERED 124
12.8.4 KEY DEVELOPMENTS 124
12.8.5 SWOT ANALYSIS 125
12.8.6 KEY STRATEGIES 125
12.9 AGFA-GEVAERT N.V. 126
12.9.1 COMPANY OVERVIEW 126
12.9.2 FINANCIAL OVERVIEW 126
12.9.3 PRODUCTS OFFERED 126
12.9.4 KEY DEVELOPMENTS 127
12.9.5 SWOT ANALYSIS 127
12.9.6 KEY STRATEGIES 127
12.10 DIGISONICS INC. 128
12.10.1 COMPANY OVERVIEW 128
12.10.2 FINANCIAL OVERVIEW 128
12.10.3 PRODUCTS OFFERED 128
12.10.4 KEY DEVELOPMENTS 128
12.10.5 SWOT ANALYSIS 129
12.10.6 KEY STRATEGIES 129
12.11 CARESTREAM HEALTH 130
12.11.1 COMPANY OVERVIEW 130
12.11.2 FINANCIAL OVERVIEW 130
12.11.3 PRODUCTS/SERVICES OFFERED 130
12.11.4 KEY DEVELOPMENTS 130
12.11.5 SWOT ANALYSIS 131
12.11.6 KEY STRATEGIES 131
12.12 EPIC SYSTEMS CORPORATION 132
12.12.1 COMPANY OVERVIEW 132
12.12.2 FINANCIAL OVERVIEW 132
12.12.3 PRODUCTS OFFERED 132
12.12.4 KEY DEVELOPMENTS 132
12.12.5 SWOT ANALYSIS 133
12.12.6 KEY STRATEGIES 133
12.13 SCIMAGE, INC. 134
12.13.1 COMPANY OVERVIEW 134
12.13.2 FINANCIAL OVERVIEW 134
12.13.3 PRODUCTS/SERVICES OFFERED 134
12.13.4 KEY DEVELOPMENTS 134
12.13.5 SWOT ANALYSIS 135
12.13.6 KEY STRATEGIES 135
13 APPENDIX 136
13.1 REFERENCES 136
13.2 RELATED REPORTS 136

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 20
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23
TABLE 3 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 39
TABLE 4 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR SOFTWARE, BY REGION, 2018–2027 (USD MILLION) 39
TABLE 5 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR SERVICES, BY REGION, 2018–2027 (USD MILLION) 39
TABLE 6 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR HARDWARE, BY REGION, 2018–2027 (USD MILLION) 40
TABLE 7 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 42
TABLE 8 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET FOR CLOUD-BASED/WEB-BASED, BY REGION, 2018–2027 (USD MILLION) 42
TABLE 9 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR ON-PREMISE, BY REGION, 2018–2027 (USD MILLION) 42
TABLE 10 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 44
TABLE 11 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET FOR CARDIAC AND PERIPHERAL CATHETERIZATION, BY REGION, 2018–2027 (USD MILLION) 44
TABLE 12 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR ECHOCARDIOGRAPHY, BY REGION, 2018–2027 (USD MILLION) 45
TABLE 13 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR HEMODYNAMICS MONITORING, BY REGION, 2018–2027 (USD MILLION) 45
TABLE 14 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR ELECTROPHYSIOLOGY, BY REGION, 2018–2027 (USD MILLION) 46
TABLE 15 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR VASCULAR ULTRASOUND, BY REGION, 2018–2027 (USD MILLION) 46
TABLE 16 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR NUCLEAR CARDIOLOGY, BY REGION, 2018–2027 (USD MILLION) 47
TABLE 17 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR ECG/STRESS/HOLTER MANAGEMENT, BY REGION, 2018–2027 (USD MILLION) 47
TABLE 18 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 48
TABLE 19 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 50
TABLE 20 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET FOR HOSPITAL & CLINICS, BY REGION, 2018–2027 (USD MILLION) 50
TABLE 21 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2018–2027 (USD MILLION) 50
TABLE 22 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR CARDIAC CATH LABS, BY REGION, 2018–2027 (USD MILLION) 51
TABLE 23 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 51
TABLE 24 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION, 2018–2027 (USD MILLION) 52
TABLE 25 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION, 2018–2027, (USD MILLION) 54
TABLE 26 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 54
TABLE 27 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 54
TABLE 28 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 55
TABLE 29 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 55
TABLE 30 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COUNTRY, 2018–2027, (USD MILLION) 56
TABLE 31 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 56
TABLE 32 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 57
TABLE 33 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 57
TABLE 34 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 57
TABLE 35 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 58
TABLE 36 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 58
TABLE 37 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 58
TABLE 38 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 59
TABLE 39 CANADA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 59
TABLE 40 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 59
TABLE 41 CANADA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 60
TABLE 42 CANADA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 60
TABLE 43 LATIN AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 61
TABLE 44 LATIN AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 61
TABLE 45 LATIN AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 61
TABLE 46 LATIN AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 62
TABLE 47 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION, 2018–2027 (USD MILLION) 63
TABLE 48 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 64
TABLE 49 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 64
TABLE 50 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 64
TABLE 51 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 65
TABLE 52 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COUNTRY, 2018–2027, (USD MILLION) 65
TABLE 53 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 66
TABLE 54 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 66
TABLE 55 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 67
TABLE 56 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 67
TABLE 57 GERMANY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 68
TABLE 58 GERMANY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 68
TABLE 59 GERMANY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 68
TABLE 60 GERMANY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 69
TABLE 61 FRANCE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 69
TABLE 62 FRANCE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 69
TABLE 63 FRANCE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 70
TABLE 64 FRANCE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 70
TABLE 65 UK: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 71
TABLE 66 UK: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 71
TABLE 67 UK: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 71
TABLE 68 UK: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 72
TABLE 69 ITALY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 72
TABLE 70 ITALY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 72
TABLE 71 ITALY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 73
TABLE 72 ITALY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 73
TABLE 73 SPAIN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 74
TABLE 74 SPAIN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 74
TABLE 75 SPAIN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 75
TABLE 76 SPAIN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 75
TABLE 77 REST OF WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 76
TABLE 78 REST OF WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 76
TABLE 79 REST OF WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 76
TABLE 80 REST OF WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 77
TABLE 81 EASTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 77
TABLE 82 EASTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 77
TABLE 83 EASTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 78
TABLE 84 EASTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 78
TABLE 85 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COUNTRY, 2018–2027, (USD MILLION) 79
TABLE 86 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 80
TABLE 87 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 80
TABLE 88 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 80
TABLE 89 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 81
TABLE 90 CHINA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 81
TABLE 91 CHINA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 81
TABLE 92 CHINA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 82
TABLE 93 CHINA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 82
TABLE 94 INDIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 83
TABLE 95 INDIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 83
TABLE 96 INDIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 83
TABLE 97 INDIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 84
TABLE 98 JAPAN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 84
TABLE 99 JAPAN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 84
TABLE 100 JAPAN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 85
TABLE 101 JAPAN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 85
TABLE 102 AUSTRALIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 86
TABLE 103 AUSTRALIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 86
TABLE 104 AUSTRALIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 86
TABLE 105 AUSTRALIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 87
TABLE 106 SOUTH KOREA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 87
TABLE 107 SOUTH KOREA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 87
TABLE 108 SOUTH KOREA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 88
TABLE 109 SOUTH KOREA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 88
TABLE 110 REST OF ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 89
TABLE 111 REST OF ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 89
TABLE 112 REST OF ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 89
TABLE 113 REST OF ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 90
TABLE 114 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION, 2018–2027 (USD MILLION) 90
TABLE 115 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 91
TABLE 116 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 91
TABLE 117 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 92
TABLE 118 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 92
TABLE 119 MIDDLE EAST: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 93
TABLE 120 MIDDLE EAST: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 93
TABLE 121 MIDDLE EAST: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 93
TABLE 122 MIDDLE EAST: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 94
TABLE 123 AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 94
TABLE 124 AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 94
TABLE 125 AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 95
TABLE 126 AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 95
TABLE 127 MAJOR PLAYERS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 96
TABLE 128 COMPETITOR DASHBOARD: GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 98
TABLE 129 ACQUISITION 98
TABLE 130 COLLABORATION 99
TABLE 131 PRODUCT LAUNCH 99
TABLE 132 PARTNERSHIP 99
TABLE 133 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED 102
TABLE 134 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED 105
TABLE 135 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS 106
TABLE 136 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED 108
TABLE 137 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS 109
TABLE 138 FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SERVICES OFFERED 111
TABLE 139 MCKESSON CORPORATION: PRODUCTS/SERVICES OFFERED 114
TABLE 140 CERNER CORPORATION: PRODUCTS OFFERED 118
TABLE 141 CERNER CORPORATION: KEY DEVELOPMENTS 118
TABLE 142 IBM WATSON HEALTH: PRODUCTS OFFERED 121
TABLE 143 IBM WATSON HEALTH: KEY DEVELOPMENTS 122
TABLE 144 LUMEDX: PRODUCTS OFFERED 124
TABLE 145 LUMEDX: KEY DEVELOPMENTS 124
TABLE 146 AGFA-GEVAERT N.V.: PRODUCTS OFFERED 126
TABLE 147 DIGISONICS INC.: PRODUCTS OFFERED 128
TABLE 148 CARESTREAM HEALTH: PRODUCTS/SERVICES OFFERED 130
TABLE 149 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED 132
TABLE 150 SCIMAGE, INC.: PRODUCTS/SERVICES OFFERED 134


LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 18
FIGURE 2 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM (CVIS) INDUSTRY MARKET 19
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 26
FIGURE 4 MARKET DYNAMICS: CARDIOVASCULAR INFORMATION SYSTEM MARKET 29
FIGURE 5 DRIVER IMPACT ANALYSIS 31
FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 33
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: CARDIOVASCULAR INFORMATION SYSTEM MARKET 35
FIGURE 8 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2020 & 2027, (USD MILLION) 38
FIGURE 9 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2020 & 2027, (USD MILLION) 41
FIGURE 10 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2020 & 2027, (USD MILLION) 43
FIGURE 11 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2020 & 2027 (USD MILLION) 49
FIGURE 12 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION 2020 & 2027 (USD MILLION) 52
FIGURE 13 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY REGION, 2020 53
FIGURE 14 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY COUNTRY, 2020 56
FIGURE 15 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY REGION, 2020 63
FIGURE 16 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY COUNTRY, 2020 66
FIGURE 17 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY COUNTRY, 2020 79
FIGURE 18 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY REGION, 2020 91
FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS 97
FIGURE 20 SALES & OPERATING INCOME, 2020 100
FIGURE 21 R&D EXPENDITURE, 2020 100
FIGURE 22 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 102
FIGURE 23 GE HEALTHCARE: SWOT ANALYSIS 103
FIGURE 24 SIEMENS HEALTHINEERS: FINANCIAL OVERVIEW SNAPSHOT 105
FIGURE 25 SIEMENS HEALTHINEERS: SWOT ANALYSIS 106
FIGURE 26 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT 108
FIGURE 27 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 109
FIGURE 28 FUJIFILM HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 111
FIGURE 29 FUJIFILM HOLDINGS CORPORATION: SWOT ANALYSIS 112
FIGURE 30 MCKESSON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 114
FIGURE 31 MCKESSON CORPORATION: SWOT ANALYSIS 115
FIGURE 32 CERNER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 117
FIGURE 33 CERNER CORPORATION: SWOT ANALYSIS 119
FIGURE 34 IBM WATSON HEALTH: FINANCIAL OVERVIEW SNAPSHOT 121
FIGURE 35 IBM WATSON HEALTH: SWOT ANALYSIS 122
FIGURE 36 LUMEDX: SWOT ANALYSIS 125
FIGURE 37 AGFA-GEVAERT N.V.: FINANCIAL OVERVIEW SNAPSHOT 126
FIGURE 38 AGFA-GEVAERT N.V.: SWOT ANALYSIS 127
FIGURE 39 DIGISONICS INC.: SWOT ANALYSIS 129
FIGURE 40 CARESTREAM HEALTH: SWOT ANALYSIS 131
FIGURE 41 EPIC SYSTEMS CORPORATION: SWOT ANALYSIS 133
FIGURE 42 SCIMAGE, INC.: SWOT ANALYSIS 135



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Cardiovascular Information System Market

Cardiovascular information system market occupies a USD 1,560.93 million, at a CAGR of 8.23% during the forecast period

Segmentation

By Component Hardware Software Services
By Delivery Mode Cloud Based/Web Based On Premise
By Application Cardiac &Peripheral Catheterization Hemodynamic Monitoring Electrophysiology Echocardiography Vascular Ultrasound Ecg/Stress/Holter Management Nuclear Cardiology
by End User Pharmaceutical & Biotechnology Companies Research & Academic Centers

Key Players

  • GE
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Siemens Healthineers
  • IBM Watson Health
  • Fujifilm Holdings Corporation
  • Cerner Corporation

Drivers

  • rise in the need to unite CVIS with CPAS/EMR
Speak to Analyst Request a Free Sample